SG11202108305TA - Therapeutically administrable high dose non-aqueous curcuminoid solutions - Google Patents

Therapeutically administrable high dose non-aqueous curcuminoid solutions

Info

Publication number
SG11202108305TA
SG11202108305TA SG11202108305TA SG11202108305TA SG11202108305TA SG 11202108305T A SG11202108305T A SG 11202108305TA SG 11202108305T A SG11202108305T A SG 11202108305TA SG 11202108305T A SG11202108305T A SG 11202108305TA SG 11202108305T A SG11202108305T A SG 11202108305TA
Authority
SG
Singapore
Prior art keywords
curcuminoid
aqueous
solutions
high dose
dose non
Prior art date
Application number
SG11202108305TA
Other languages
English (en)
Inventor
Joseph Halstead
Original Assignee
Joseph Halstead
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2019900438A external-priority patent/AU2019900438A0/en
Application filed by Joseph Halstead filed Critical Joseph Halstead
Publication of SG11202108305TA publication Critical patent/SG11202108305TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202108305TA 2019-02-11 2020-02-05 Therapeutically administrable high dose non-aqueous curcuminoid solutions SG11202108305TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2019900438A AU2019900438A0 (en) 2019-02-11 An administrable curcuminoid solution and method of production thereof
PCT/AU2020/050081 WO2020163899A1 (en) 2019-02-11 2020-02-05 Therapeutically administrable high dose non-aqueous curcuminoid solutions

Publications (1)

Publication Number Publication Date
SG11202108305TA true SG11202108305TA (en) 2021-08-30

Family

ID=72043747

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108305TA SG11202108305TA (en) 2019-02-11 2020-02-05 Therapeutically administrable high dose non-aqueous curcuminoid solutions

Country Status (12)

Country Link
US (1) US20220184001A1 (de)
EP (1) EP3897598B1 (de)
JP (1) JP2022520778A (de)
KR (1) KR20210126016A (de)
CN (1) CN113423393A (de)
AU (1) AU2020204501B2 (de)
BR (1) BR112021015505A2 (de)
CA (1) CA3127506A1 (de)
IL (1) IL285425A (de)
PL (1) PL3897598T3 (de)
SG (1) SG11202108305TA (de)
WO (1) WO2020163899A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008042944A2 (en) * 2006-10-05 2008-04-10 The Trustees Of Columbia University In The City Of New York Non-irritating oral care formulations
EP2448416A4 (de) * 2009-06-30 2013-03-20 Univ Columbia Antimikrobielle/konservierende zusammensetzungen mit pflanzlichen stoffen
CN102225048A (zh) * 2011-04-27 2011-10-26 中国人民解放军第二军医大学 一种姜黄素类化合物注射溶液及其静脉注射剂
JP6553080B2 (ja) * 2013-12-09 2019-07-31 サステイナルーベ アーベー 水性潤滑剤組成物、その製造方法、及びその使用

Also Published As

Publication number Publication date
PL3897598T3 (pl) 2024-06-03
WO2020163899A1 (en) 2020-08-20
CN113423393A (zh) 2021-09-21
EP3897598B1 (de) 2024-03-20
EP3897598A4 (de) 2022-09-14
IL285425A (en) 2021-09-30
EP3897598C0 (de) 2024-03-20
AU2020204501B2 (en) 2020-09-10
KR20210126016A (ko) 2021-10-19
US20220184001A1 (en) 2022-06-16
CA3127506A1 (en) 2020-08-20
AU2020204501A1 (en) 2020-08-27
JP2022520778A (ja) 2022-04-01
EP3897598A1 (de) 2021-10-27
BR112021015505A2 (pt) 2021-10-05

Similar Documents

Publication Publication Date Title
GB201905286D0 (en) Mass spectrometerhaving improved quadrupole robustness
GB2588344B (en) Segmented vapor plug
IL288517A (en) Closed system drug delivery devices for solid dosage forms
EP4041750A4 (de) Dosierungen zur hdac-behandlung mit reduzierten nebenwirkungen
GB201900702D0 (en) Therapy
SG11202108736WA (en) Intent-driven contact center
GB202105225D0 (en) Non-aqueous solutions for oral dosage
EP3958454A4 (de) Festkörpertransformator
GB2572846B (en) Quadrupole devices
GB2584757B (en) Quadrupole devices
GB201805299D0 (en) Deformation correction
EP4085296A4 (de) Kontaktlinsen mit zwei konfigurationen
IL285425A (en) High-dose therapeutic, non-aqueous curcuminoid solutions
GB201908885D0 (en) Therapeutic compounds
EP3775741A4 (de) Trockenblaskammer
GB201903213D0 (en) Quadrupole devices
GB201903214D0 (en) Quadrupole devices
GB201911296D0 (en) Pancakes
GB2584089B (en) Cleaning ion optic multipole devices
GB201914108D0 (en) Contact
GB201909280D0 (en) Solid dose formulation
GB201911580D0 (en) Therapeutic compounds
GB201911574D0 (en) Therapeutic compounds
GB201907213D0 (en) Spectrometers
GB201907813D0 (en) Therapeutic compounds